← Eichor
Study identifier: NCT06517927 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10

Condition: Chemotherapy Effect · Dental Caries · Malocclusion  ·  Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

PhaseNA
Planned participants142
Who can joinAll sexes, 12 Years to 36 Years
Healthy volunteersNo

About this study

To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development. The aims of this study are : * Assess the caries risk in childhood cancer survivors compared with a control group. * Assess the dental development defects risk in childhood cancer survivors compared with a control group.

This description comes directly from the study's public registry record.

Talk to the study team

Armand IRAKOZE  ·  027645741  ·  armand.irakoze@uclouvain.be

Always discuss trial participation with your own doctor first.

Locations (1)

Cliniques universitaires Saint-LucBrussels, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06517927